GlassScriptPhysician profile
Mary A Ozee
NPI 1780690388
$3,741.65
in general payments reported to CMS, 2019-2025
36 companies · $905 in 2025
The $905 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $639 · 2022: $641 · 2023: $814 · 2024: $742 · 2025: $905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,461.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $911.68 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $353.44 | 2021-2025 | |
| Glaxosmithkline, LLC. | $264.57 | 2021-2025 | Trelegy Ellipta, Shingrix, Bexsero |
| Novo Nordisk INC | $260.66 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $258.92 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $217.18 | 2021-2025 | Spravato |
| Vanda Pharmaceuticals INC. | $148.43 | 2021-2025 | Fanapt, Hetlioz |
| Lilly USA, LLC | $142.30 | 2021-2025 | Mounjaro, Zepbound, Emgality |
| Dexcom, INC. | $124.99 | 2023-2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $95.00 | 2023-2025 | Rexulti, Abilify Maintena, Nuedexta |
| Axsome Therapeutics, INC. | $94.30 | 2023-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $89.17 | 2024-2025 | Ingrezza |
| Merck Sharp & Dohme LLC | $69.86 | 2021-2023 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Exact Sciences Corporation | $65.41 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $57.08 | 2023-2024 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Ozee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.